FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000984914> ?p ?o ?g. }

• W2000984914 endingPage "929" @default.
• W2000984914 startingPage "920" @default.
• W2000984914 abstract "The high prevalence of comorbidity among HIV-infected patients in care such as hepatitis C virus (HCV) coinfection and mental illness may contribute to increased toxicity and decreased adherence to highly active antiretroviral therapy (HAART). Newer HAART regimens have less toxicity and better dosing characteristics than first-generation regimens, but it is not known whether they are associated with improved clinical outcomes. The purpose of this study was to examine the effect of patient factors and initial HAART regimen on survival among HIV-infected patients in routine care. We conducted an observational study of all HAART-naïve patients in the University of Washington HIV cohort who initiated HAART between January 1996 and October 2005. Cox survival analyses were used to examine the association between time to death and treatment with first-generation protease inhibitors (PIs; indinavir, ritonavir, saquinavir), newer PIs (amprenavir, atazanavir, lopinavir, nelfinavir), efavirenz, or nevirapine, controlling for baseline characteristics, and calendar period. Of 694 patients, 84 (12%) died. In adjusted analyses, patients treated with a first-generation PI (hazard ratio [HR] 1.9, p = 0.04) or nevirapine (HR 2.0, p = 0.046) had twice the risk of death compared with those receiving a newer PI. Survival for patients treated with efavirenz did not differ from those receiving a newer PI (HR 1.1, p = 0.8). Greater disease severity (HR 1.7, p = 0.03), hepatitis C virus (HCV; HR 1.6, p = 0.05), and depression (HR 2.0, p = 0.007) were independent predictors of increased mortality. This study demonstrates significant improvement in survival among patients initiating HAART with newer PIs compared to first-generation PIs or nevirapine, and highlights the complexity of patient factors affecting the clinical outcomes of treatment." @default.
• W2000984914 created "2016-06-24" @default.
• W2000984914 creator A5050408475 @default.
• W2000984914 creator A5058728247 @default.
• W2000984914 creator A5077239845 @default.
• W2000984914 date "2007-12-01" @default.
• W2000984914 modified "2023-09-24" @default.
• W2000984914 title "Initiating Highly Active Antiretroviral Therapy with Newer Protease Inhibitors Is Associated with Better Survival Compared to First-Generation Protease Inhibitors or Nevirapine" @default.
• W2000984914 cites W1516893700 @default.
• W2000984914 cites W1964923982 @default.
• W2000984914 cites W1973074600 @default.
• W2000984914 cites W1976431061 @default.
• W2000984914 cites W1992192692 @default.
• W2000984914 cites W1993443901 @default.
• W2000984914 cites W1997671881 @default.
• W2000984914 cites W2013788600 @default.
• W2000984914 cites W2019069506 @default.
• W2000984914 cites W2022649583 @default.
• W2000984914 cites W2034482023 @default.
• W2000984914 cites W2037036212 @default.
• W2000984914 cites W2038727335 @default.
• W2000984914 cites W2056118379 @default.
• W2000984914 cites W2056271343 @default.
• W2000984914 cites W2063611994 @default.
• W2000984914 cites W2071680567 @default.
• W2000984914 cites W2078978810 @default.
• W2000984914 cites W2107003598 @default.
• W2000984914 cites W2119874144 @default.
• W2000984914 cites W2123087672 @default.
• W2000984914 cites W2141776019 @default.
• W2000984914 cites W2155449170 @default.
• W2000984914 cites W2156380404 @default.
• W2000984914 cites W2160997908 @default.
• W2000984914 cites W2164099498 @default.
• W2000984914 cites W2168788923 @default.
• W2000984914 cites W2169090314 @default.
• W2000984914 cites W2170464565 @default.
• W2000984914 cites W2316853826 @default.
• W2000984914 cites W2318465420 @default.
• W2000984914 cites W2329393410 @default.
• W2000984914 cites W4243157546 @default.
• W2000984914 doi "https://doi.org/10.1089/apc.2007.0020" @default.
• W2000984914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18154489" @default.
• W2000984914 hasPublicationYear "2007" @default.
• W2000984914 type Work @default.
• W2000984914 sameAs 2000984914 @default.
• W2000984914 citedByCount "10" @default.
• W2000984914 countsByYear W20009849142012 @default.
• W2000984914 countsByYear W20009849142015 @default.
• W2000984914 countsByYear W20009849142017 @default.
• W2000984914 countsByYear W20009849142018 @default.
• W2000984914 countsByYear W20009849142022 @default.
• W2000984914 crossrefType "journal-article" @default.
• W2000984914 hasAuthorship W2000984914A5050408475 @default.
• W2000984914 hasAuthorship W2000984914A5058728247 @default.
• W2000984914 hasAuthorship W2000984914A5077239845 @default.
• W2000984914 hasConcept C126322002 @default.
• W2000984914 hasConcept C142462285 @default.
• W2000984914 hasConcept C181199279 @default.
• W2000984914 hasConcept C185592680 @default.
• W2000984914 hasConcept C203014093 @default.
• W2000984914 hasConcept C207103383 @default.
• W2000984914 hasConcept C2776714187 @default.
• W2000984914 hasConcept C2776937687 @default.
• W2000984914 hasConcept C2777182164 @default.
• W2000984914 hasConcept C2777210460 @default.
• W2000984914 hasConcept C2777363262 @default.
• W2000984914 hasConcept C2777583353 @default.
• W2000984914 hasConcept C2777813720 @default.
• W2000984914 hasConcept C2778414717 @default.
• W2000984914 hasConcept C2779130552 @default.
• W2000984914 hasConcept C2779298103 @default.
• W2000984914 hasConcept C2781143361 @default.
• W2000984914 hasConcept C2781160516 @default.
• W2000984914 hasConcept C2781413609 @default.
• W2000984914 hasConcept C2781432083 @default.
• W2000984914 hasConcept C2993143319 @default.
• W2000984914 hasConcept C3013748606 @default.
• W2000984914 hasConcept C44249647 @default.
• W2000984914 hasConcept C55493867 @default.
• W2000984914 hasConcept C71924100 @default.
• W2000984914 hasConceptScore W2000984914C126322002 @default.
• W2000984914 hasConceptScore W2000984914C142462285 @default.
• W2000984914 hasConceptScore W2000984914C181199279 @default.
• W2000984914 hasConceptScore W2000984914C185592680 @default.
• W2000984914 hasConceptScore W2000984914C203014093 @default.
• W2000984914 hasConceptScore W2000984914C207103383 @default.
• W2000984914 hasConceptScore W2000984914C2776714187 @default.
• W2000984914 hasConceptScore W2000984914C2776937687 @default.
• W2000984914 hasConceptScore W2000984914C2777182164 @default.
• W2000984914 hasConceptScore W2000984914C2777210460 @default.
• W2000984914 hasConceptScore W2000984914C2777363262 @default.
• W2000984914 hasConceptScore W2000984914C2777583353 @default.
• W2000984914 hasConceptScore W2000984914C2777813720 @default.
• W2000984914 hasConceptScore W2000984914C2778414717 @default.
• W2000984914 hasConceptScore W2000984914C2779130552 @default.
• W2000984914 hasConceptScore W2000984914C2779298103 @default.
• W2000984914 hasConceptScore W2000984914C2781143361 @default.

• next